Organización Nacional De Trasplantes-ko ikertzaileekin lankidetzan egindako argitalpenak (17)

2024

  1. GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study

    eClinicalMedicine, Vol. 74

  2. Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch

    Transplantation, Vol. 108, Núm. 3, pp. 787-801

  3. Toward a Fair Adjusted Analysis of Kidney Graft Survival

    Transplantation

2023

  1. Erratum to “Recommendations for living donor kidney transplantation” (NEFROLOGÍA (2022) 42(S2) (129–132), (S0211699522000133), (10.1016/j.nefro.2022.01.007))

    Nefrologia

2022

  1. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss

    American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181

  2. Live donor kidney transplantation. Situation analysis and roadmap

    Nefrologia, Vol. 42, Núm. 1, pp. 85-93

2021

  1. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

    Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155

  2. Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells

    Stem Cell Research and Therapy, Vol. 12, Núm. 1

2019

  1. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation

    Journal of Hepatology, Vol. 70, Núm. 4, pp. 658-665

  2. Reply to: “Normothermic regional perfusion – What is the benefit?”

    Journal of Hepatology

  3. The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation

    Journal of Hepatology

2018

  1. Analysis of the Spanish CCR5-Δ32 inventory of cord blood units: Lower cell counts in homozygous donors

    Bone Marrow Transplantation, Vol. 53, Núm. 6, pp. 741-748

  2. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2016

  1. Erratum: Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study (Journal of Hepatology (2015) 62 (92-100))

    Journal of Hepatology

  2. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

2015

  1. Activity and results of liver transplantation in Spain during 1984-2012. Analysis of the Spanish Liver Transplant Registry

    Medicina Clinica, Vol. 144, Núm. 8, pp. 337-347

  2. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study

    Journal of Hepatology, Vol. 62, Núm. 1, pp. 92-100